TY - JOUR
T1 - Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for hodgkin's disease
AU - Salvagno, Luigi
AU - Sorarú, Mariella
AU - Leszl, Anna
AU - Koussis, Haralabos
AU - Franchise, Giuseppe De
AU - Fiorentino, Mario V.
PY - 1994
Y1 - 1994
N2 - A case of secondary chronic myelogenous leukemia after successful therapy for Hodgkin's disease is reported. The patient was diagnosed as having stage IIIA Hodgkin's disease, at the age of 33. He underwent staging laparosplenectomy and was treated with radiotherapy plus chemotherapy. Forty three months after the diagnosis of Hodgkin's disease, a Philadelphia-positive chronic myelogenous leukemia developed. It required periodic chemotherapy and each time a remission, lasting several months (up to 14 months), was obtained. The disease had an unusually prolonged clinical course, and the blast crisis, of lymphoid type, occurred only 17 years later.
AB - A case of secondary chronic myelogenous leukemia after successful therapy for Hodgkin's disease is reported. The patient was diagnosed as having stage IIIA Hodgkin's disease, at the age of 33. He underwent staging laparosplenectomy and was treated with radiotherapy plus chemotherapy. Forty three months after the diagnosis of Hodgkin's disease, a Philadelphia-positive chronic myelogenous leukemia developed. It required periodic chemotherapy and each time a remission, lasting several months (up to 14 months), was obtained. The disease had an unusually prolonged clinical course, and the blast crisis, of lymphoid type, occurred only 17 years later.
KW - Chronic myelogenous leukemia
KW - Hodgkin's disease
KW - Secondary leukemia
UR - http://www.scopus.com/inward/record.url?scp=0028596131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028596131&partnerID=8YFLogxK
U2 - 10.3109/10428199409114156
DO - 10.3109/10428199409114156
M3 - Article
C2 - 7696925
AN - SCOPUS:0028596131
VL - 16
SP - 177
EP - 181
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 1-2
ER -